Category Archives: Neuroscience

Science Meets Science-Fiction – with Dr Christine Aicardi June 13th 6:30-8 pm

Dr Christine Aicardi, Foresight Lab of the Department of Global Health & Social Medicine at King’s, and SciFi authors Pippa Goldschmidt, Stephen Oram and Geoff Ryman, have collaborated with scientists in the Department of Developmental Neurobiology and the Department of Twin … Continue reading

Posted in Narrative Medicine, Neuroscience | Tagged , | Leave a comment

New book edited by Tara Mahfoud, Sam McLean and Nikolas Rose “Vital Models”: The Making and Use of Models in the Brain Sciences

The use of models has been important to the historical and contemporary study of the human brain, yet very little study by social scientists and humanities scholars has been dedicated to how the brain sciences develop and use models to … Continue reading

Posted in Neuroscience, Sociology | Tagged , , , | Leave a comment

SSHM Annual Lecture May 11: “The Genetics of Mental Disorders: Exorcising Kraepelin’s Ghost”

We are delighted to announce that the SSHM annual lecture will be given by Professor Steve Hyman, Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard) When: Monday May 11, 2015  18.00 – 20.30 Where:  Old … Continue reading

Posted in Neuroscience, Psychiatry | Tagged , , , | 1 Comment

Next meetings BESJ Reading Group “The mismeasure of man”

Please note the following changes to the meetings of the BESJ Reading Group: We are rescheduling the BESJ Reading Group on Stephen Jay Gould‘s “The mismeasure of man” to Friday Janiary 30th, and to February 6th, at 430 pm (please note not 4 pm as previously … Continue reading

Posted in Bioethics, Neuroscience | Tagged , , | Leave a comment

FDA Approves Lemtrada for MS: Dr Lara Marks recounts the story of the drug in “The life story of a Biotechnology drug: Alemtuzumab”

On November 14 2014 the FDA announced the approval of Lemtrada (alemtuzumab) as a treatment for patients with relapsing forms of multiple sclerosis (MS) who have previously failed two other drugs. This decision marked the culmination of a long and … Continue reading

Posted in Health Policy, Neuroscience | Tagged , , , | Leave a comment